Oncimmune Holdings (GB:ONC) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Oncimmune Holdings is raising a minimum of £2.0 million through a combination of placing, subscription, and retail offers to support its growth and strengthen its balance sheet. The company is converting €4.0 million of existing debt into equity, aiming to enhance commercial traction and capitalize on recent contract wins with major pharmaceutical companies. This financial strategy is expected to drive the commercialization of Oncimmune’s autoantibody profiling platform.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.
